S&T (SANT) Given a €28.50 Price Target by Hauck & Aufhaeuser Analysts

Share on StockTwits

Hauck & Aufhaeuser set a €28.50 ($33.14) price objective on S&T (ETR:SANT) in a report published on Thursday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

A number of other brokerages have also issued reports on SANT. Warburg Research set a €25.00 ($29.07) price target on S&T and gave the stock a neutral rating in a research note on Friday, April 5th. Kepler Capital Markets set a €27.00 ($31.40) price target on S&T and gave the stock a buy rating in a research note on Wednesday, April 17th. Finally, HSBC set a €28.00 ($32.56) price target on S&T and gave the stock a buy rating in a research note on Thursday, May 9th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of Buy and an average target price of €27.10 ($31.51).

Shares of SANT stock opened at €20.04 ($23.30) on Thursday. S&T has a 52-week low of €15.20 ($17.67) and a 52-week high of €28.06 ($32.63). The company has a quick ratio of 1.18, a current ratio of 1.66 and a debt-to-equity ratio of 33.83. The firm has a market capitalization of $1.32 billion and a price-to-earnings ratio of 27.91.

About S&T

S&T AG develops, implements, and markets IT hardware, solutions, and services primarily in Germany, Austria, Switzerland, Eastern Europe, and North America. It operates through three segments: IT services, IoT Solutions, and Embedded Systems. The company offers devices for workplaces, such as desktops, notebooks, and tablets; external hard disks and fan less devices, as well as peripherals, including monitors and printers; and special solutions for POS comprising checkout systems, self-service terminals, and electronic advertising spaces.

Featured Article: What are trading strategies for the 52-week high/low?

Analyst Recommendations for S&T (ETR:SANT)

Receive News & Ratings for S&T Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for S&T and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Comparing ENDRA Life Sciences  and The Competition
Comparing ENDRA Life Sciences and The Competition
Head-To-Head Comparison: CHESAPEAKE FINL/SH  versus Washington Federal
Head-To-Head Comparison: CHESAPEAKE FINL/SH versus Washington Federal
China Jo-Jo Drugstores  vs. 111  Head-To-Head Contrast
China Jo-Jo Drugstores vs. 111 Head-To-Head Contrast
Critical Analysis: Workhorse Group  & PACCAR
Critical Analysis: Workhorse Group & PACCAR
Reviewing Axos Financial  and BBX Capital
Reviewing Axos Financial and BBX Capital
Transatlantic Capital  and Digipath  Critical Survey
Transatlantic Capital and Digipath Critical Survey


© 2006-2019 Ticker Report